Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy

Chemotherapy dosages are often compromised, but most reports lack data on dosages that are actually delivered. In two consecutive acute lymphoblastic leukemia trials that differed in their asparaginase formulation, native E. coli L-asparaginase in St. Jude Total 15 (T15, n=365) and pegaspargase in T...

Descripción completa

Detalles Bibliográficos
Autores principales: Karol, Seth E., Pei, Deqing, Smith, Colton A., Liu, Yiwei, Yang, Wenjian, Kornegay, Nancy M., Panetta, John C., Crews, Kristine R., Cheng, Cheng, Finch, Emily R., Inaba, Hiroto, Metzger, Monika L., Rubnitz, Jeffrey E., Ribeiro, Raul C., Gruber, Tanja A., Yang, Jun J., Evans, William E., Jeha, Sima, Pui, Ching-Hon, Relling, Mary V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804576/
https://www.ncbi.nlm.nih.gov/pubmed/34196166
http://dx.doi.org/10.3324/haematol.2021.278411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804576/
https://www.ncbi.nlm.nih.gov/pubmed/34196166
http://dx.doi.org/10.3324/haematol.2021.278411

Ejemplares similares